Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
There are numerous filling materials used in daily clinical practice for cosmetic and medical purposes, they can be classified: depending on their duration in the tissue (temporary, semi-permanent and permanent), they can also be classified according to the composition of the filling as: collagen (bovine, porcine) and human), hyaluronic acid, polylactic acid, calcium hydroxyapatite, sodium hyaluronate, polymethyl methacrylates and depolyacrylamide gels, among others.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer has detected that the raw material of the gauze packaging, in this case the medical grade paper, does not present enough and necessary adhesion with the film, for this reason, when both (paper and film) are sealed, the result is unsello with a weak force and this, added to the weight of the gas, causes the product to open easily, compromising the sterility of the product, which can lead to potentially serious adverse events on the patients.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer states that the medical device may not offer a fully atomized peel to the medication, jeopardizing the effectiveness of the medication with which it is used, leading to the presentation of possible adverse events on patients.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer reports that it has detected that some of the referenced devices are not completely atomizing, so that it may impair the effectiveness of the medication with which it is used, leading to possible delays in the procedures, ineffectiveness of the treatment and adverse events on the patients.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer states that the referenced equipment was equipped with the wrong bipolar pedal for the activation of its bipolar functions, reference fs-18 instead of the fs-23, when the equipment is used with the wrong pedal the main functions of the equipment are conserved, except the bipolar function that will present failures, leading to the potential generation of adverse events on patients or delays in surgical times.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
It is reported by the importer that the referenced devices were conditioned with a labeling that does not correspond to him, because of an official of the company, which is why the product is withdrawn from the market in a preventive manner, as it does not comply with the requirements of the technical and legal provisions regulating it are considered as fraudulent products.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer reports that it has detected that due to a manufacturing error, the referenced devices may contain variable amounts of contrast medium below the specification, causing the impairment of visibility under x-rays, resulting in possible intraoperative and postoperative damage, the health professionals that they have implanted patients should continue the follow-up according to the usual care protocol, since the situation described could lead to possible adverse events on the patients.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer has detected that if the incubation time parameters are changed when creating a user defined protocol (udp) test, then the incubation time of the ortho test template and other udp tests created from the same template the test can change, leading to errors in the processing, obtaining deviations from the results.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer has detected a possible security problem where after making a request for reload / download of reagents, a user withdraws or exchanges samples in a sample rack on board or removes a dilution rack in a location that was not selected in the user graphic interface (gui) ) and the system will not detect the change, leading to potential delays in the processing of the samples or errors in their processing, obtaining deviations in the results.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer has detected a possible security problem where the software incorrectly interprets for one day the built-in expiration dates of 2016-02-29 and later that are on the labels with code debarras (barcodes) for ortho reagent products, the miscalculation of the date of the expiration of the reagent existed since february 29 and will continue until the end of 2016, leading to potential delays in the processing of the samples.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer has detected a problem of alignment of the front panel bevel, the plastic cover around the ports of the transducer prevents connecting the transducer to the corresponding port, resulting in the blockage of the system, which could lead to potential delays in attention from the patients.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The manufacturer indicates that with the high definition transducers 6c1, as with the 18l6 hd transducer, errors can be presented when using the instructions that appear on the screen, this problem occurs with greater incidence when using civco biopsy connectors, likewise describe possible alignment errors in the measurement tool when repositioning the iq virtual interest region from its default location, leading to the occurrence of possible serious adverse events on the patient.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
Invima informs that through ivc's visit it was possible to prove that the referenced product was commercialized without complying with the full requirements required by the technical and legal provisions that regulate it, being marketed without lot number, for which the product withdrawal was requested. market in a preventive manner, because it is considered a fraudulent product.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
The importer informs that the invima in the development of its functions of inspection, surveillance and control ordered the removal of all products that came under the presentation of three brushes with the protectors of each brush along with a dental floss which seunen through a blister pack , presentation that has not been authorized in the sanitary registries corresponding to said products.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
Notes supplémentaires dans les données
Cause
It is reported by the manufacturer that at the time of extracting from the hospital information system (his / ris) a large number of examinations of different patients, the examinations may not correspond to the correct patient, leading to diagnostic errors and potentially adverse events on the patient. patient.